Navigation Links
Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A 'Clean Slate' Approach to the Practice of Pharmaceutical Care
Date:3/27/2008

MOORESTOWN, N.J., March 27 /PRNewswire/ -- In response to the growing demand for solutions to the problem with medication use in the United States, a group of entrepreneurs has established Tabula Rasa Strategies(TM), LLC (TR-Strategies(TM)), a pharmaceutical care consulting firm with over 25 years experience in pharmacy practice, to help organizations develop strategies to implement pharmaceutical care, and "Inspire Pharmacists to Practice Successfully with Meaning(TM)."

"Numerous studies have established the clinical, humanistic, and economic outcome benefits of having pharmacists positioned as medication management experts and their role in pharmaceutical care practice. Yet, except in closed healthcare systems such as the VA or Kaiser Permanente, pharmacists' expertise has not been leveraged in a way that benefits patients and other healthcare providers," said Calvin Knowlton, BSPharm, MDiv, PhD, Founder & CEO, TR-Strategies. "The concept phase of pharmaceutical care has been a tremendous success. It is now time to fully leverage pharmacists as pivotal members of the healthcare team. We believe that positioning pharmacists as medication management experts in the provision of pharmaceutical care will result in marked reduction in healthcare costs as a result of reducing the problems of medication use through education, monitoring, and tracking of patient outcomes. Positioning pharmacists to positively affect patient care is our core competency."

"While Congress may have recognized the value of pharmacists when they included 'Medication Management Services' (MTM) in Medicare Part D, the model of care, as well as a pharmacist-centric mandate, were not well-defined. This has led to the implementation of marginalized program offerings to meet the Part D requirement for MTM services, with no system or method of measuring the outcome of this $50 billion per year benefit for Medicare Beneficiaries," said President, Orsula Voltis Knowlton, PharmD, MBA. "Patient compliance or adherence, often looked to as medication-related outcome measure, is not the primary issue related to the inappropriate use of medication. With better selection and monitoring, adherence would be very much a secondary issue, mostly related to the cost of medications, not their side-effects. Pharmacist-driven medication management helps patients avoid medication problems by assuring the appropriate use of medication, prior to taking them, and through ongoing patient monitoring in partnership with the patient, prescriber and other care providers."

"Automating the dispensing functions of pharmacy is a key strategy that enables clinically trained pharmacists to work with other healthcare providers to focus on patients, and not pills," said Jim Goers, RPh, also a member of the TR-Strategies team. "Pharmacy automation reduces the risk of human error in the dispensing process and increases resources available for clinical functions, but does not assure that the medication itself is appropriate for the patient. This is the role of the pharmaceutical care practicing pharmacist -- assuring appropriate medication selection."

The most recent study of the cost of medication-related morbidity and mortality found that $177 billion was spent in the year 2000 to treat the problems associated with medication, which is more than was spent on the cost of medications themselves, according to the Cost of Illness Model, published in the Journal of the American Pharmacists Association, 2001, by Ernst and Grizzle. Numerous studies have been published that underscore the benefits of clinical pharmacist-driven pharmaceutical care including reduced overall costs of healthcare, fewer emergency room and physician visits, and initial or extended hospitalizations. American Pharmacist Foundation Projects such as Project ImPACT, the Asheville Project, the Patient Self-Management Program for Diabetes and the Diabetes 10 City Challenge have found improved patient outcomes and reduced overall costs as a result of community pharmacist-driven pharmaceutical care.

Tabula Rasa Strategies(TM), LLC, is a pharmaceutical care company collaborating with clients to assess specific needs in order to frame a provision of consulting, strategic, and educational solutions in the following areas: Pharmaceutical Care, Applied Ethics, Spirituality and Healthcare, Leadership in Pharmacy, Pharmacy Automation and Operations, Pharmacy Speakers Bureaus, Organizational Management and other strategically focused consulting services. For more information about TR-Strategies visit http://www.tr-strategies.com, e-mail TRInfo@TR-Strategies.com or call 856-273-7534. For more information about medication management and pharmaceutical care, visit http://www.pharmacists.com/mtm.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Tabula Rasa Strategies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Smith & Nephew Launches R3(TM) Acetabular System a Revolution in Hip Motion
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College ... nursing professionals advance their careers. Beginning in the fall of 2017, Emmanuel’s program will ... in as few as 16 months and for as little as $14,528. These changes ...
(Date:4/24/2017)... ... 24, 2017 , ... Michael Vick announced his retirement earlier this year from ... overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, made ... the most career rushing yards by a quarterback (6,109) and the most rushing yards ...
(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director ... Communication of Education Research Award. The award honors scholars exemplary in their capacity ... a scholar who has demonstrated the capacity to deepen the public’s understanding and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
Breaking Medicine Technology: